Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.35
-0.07-2.89%
Last update: Oct 16, 4:01 PM
$2.35
-0.07-2.89%
Minerva Neurosciences Inc (NERV) Stock Price, Quote, News & History
NERVNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Minerva Neurosciences (NASDAQ:NERV) through any online brokerage.
Other companies in Minerva Neurosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Minerva Neurosciences has a consensus price target of $10.33.
The stock price for Minerva Neurosciences (NASDAQ: NERV) is $2.35 last updated October 16, 2026 at 4:01 PM EDT.
There are no upcoming dividends for Minerva Neurosciences.
Minerva Neurosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Minerva Neurosciences.
Minerva Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
